Mark James Litton Sells 25,107 Shares of Athira Pharma, Inc. (NASDAQ:ATHA) Stock
Athira Pharma, Inc. (NASDAQ:ATHA – Get Free Report) CEO Mark James Litton sold 25,107 shares of Athira Pharma stock in a transaction dated Thursday, January 2nd. The stock was sold at an average price of $0.56, for a total value of $14,059.92. Following the sale, the chief executive officer now directly owns 242,591 shares of […]
More Stories
CIBC Private Wealth Group LLC Has $33,000 Stock Position in Fox Co. (NASDAQ:FOXA)
CIBC Private Wealth Group LLC increased its holdings in shares of Fox Co. (NASDAQ:FOXA – Free Report) by 122.3% during...
O Shaughnessy Asset Management LLC Sells 1,036 Shares of Qualys, Inc. (NASDAQ:QLYS)
O Shaughnessy Asset Management LLC reduced its stake in Qualys, Inc. (NASDAQ:QLYS – Free Report) by 21.2% in the fourth...
O Shaughnessy Asset Management LLC Purchases 1,308 Shares of Samsara Inc. (NYSE:IOT)
O Shaughnessy Asset Management LLC increased its stake in Samsara Inc. (NYSE:IOT – Free Report) by 11.3% in the fourth...
O Shaughnessy Asset Management LLC Purchases 1,308 Shares of Samsara Inc. (NYSE:IOT)
O Shaughnessy Asset Management LLC increased its stake in Samsara Inc. (NYSE:IOT – Free Report) by 11.3% in the fourth...
Wellington Management Group LLP Boosts Holdings in The Vita Coco Company, Inc. (NASDAQ:COCO)
Wellington Management Group LLP lifted its stake in shares of The Vita Coco Company, Inc. (NASDAQ:COCO – Free Report) by...
Wellington Management Group LLP Boosts Holdings in The Vita Coco Company, Inc. (NASDAQ:COCO)
Wellington Management Group LLP lifted its stake in shares of The Vita Coco Company, Inc. (NASDAQ:COCO – Free Report) by...